PGE2/TXB2 imbalance in neonatal hypoxemic respiratory failure

Acta Paediatr. 2007 May;96(5):669-73. doi: 10.1111/j.1651-2227.2007.00237.x. Epub 2007 Mar 21.

Abstract

Background: An imbalance of vaso-constrictor and -dilator mediators has been implicated in the pathogenesis of the pulmonary hypertension accompanying neonatal hypoxemic respiratory failure (NHRF).

Aim: To characterize plasma PGE2, TXB2 and their ratio in normal newborns and in those with NHRF.

Methods: Twenty newborns with NHRF received inhaled PGE1 (IPGE1) by jet nebulizer in doses of 25, 50, 150 and 300 ng/kg/min followed by weaning. Blood for PGE2 and TXB2 assay using EIA was available in 8 neonates with NHRF prior to IPGE1. Umbilical cord arterial samples were also obtained at delivery from 10 normal newborns to serve as controls.

Results: Compared to normal newborns, those with NHRF had significantly lower PGE2/TXB2 ratios after controlling for preterm gestation (< 37 weeks) and postnatal age (p < 0.05). Notably, all subjects except one in the NHRF group had a value of < 1.0 (range 0.1-1.2) compared to a value of > 1.0 in all subjects in the Control group (range 1.1-5.2).

Conclusions: Lower PGE2/TXB2 ratio in subjects with NHRF compared with controls reflects a predominance of vaso-constrictor activity in these patients as the basis of pulmonary hypertension. Plasma PGE2/TXB2 ratio may have important implications for the diagnosis and treatment of NHRF.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Dinoprostone / metabolism*
  • Female
  • Humans
  • Hypoxia / metabolism*
  • Hypoxia / physiopathology
  • Infant, Newborn
  • Male
  • Pilot Projects
  • Respiratory Insufficiency / metabolism*
  • Respiratory Insufficiency / physiopathology
  • Thromboxane B2 / metabolism*

Substances

  • Thromboxane B2
  • Dinoprostone